US inroads to better Ebola vaccine

(Flinders University) As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses. In the latest collaboration with US partners, a vaccine turbocharger called Advax ™ adjuvant, was combined with a synthetic protein against Ebola developed by the United States Army Medical Research Institute of Infectious Disease (USAMRIID).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news